Cellyan Biotechnology Co., Ltd (HKPD) stock
HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
$1.52−0.09 (-5.30%)
Close on Nov 17, 2026Market cap $24.93MP/E –Yield –
Cellyan Biotechnology profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2026 it was -8.5%, against -0.1% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -8.5% | −8.3 |
| FY2025 | Mar 31, 2025 | -0.1% | −8.1 |
| FY2024 | Mar 31, 2024 | 8.0% | +0.0 |
| FY2023 | Mar 31, 2023 | 7.9% | – |
See a number that looks wrong?